Trial intelligence / Profile preview

Zi Gui Nv Zhen capsule for infertility associated with thin endometrium or diminished ovarian reserve

ChiCTR1800020269Phase 4Recruiting

Sponsor
Beijing Obstetrics and Gynecology Hospital
Start
Jul 2018
Countries
1
01

Overview

Phase 4, open-label trial of Zi Gui Nv Zhen in infertility, Diminished Ovarian Reserve (DOR) and Endometrial hypotrophy (2 cohorts), sponsored by Beijing Obstetrics and Gynecology Hospital. Primary endpoints: follicle-stimulating hormone, luteinizing hormone and 1 more. Started Jul 2018; status: recruiting.

02

Drugs

Zi Gui Nv Zhen
03

Conditions

infertilityDiminished Ovarian Reserve (DOR)Endometrial hypotrophy

Beyond the preview

Go deeper on ChiCTR1800020269.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800020269.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call